Skip to content
DNAnexus
DNAnexus
  • Solutions
    • INDUSTRIES
      Bioinformatician-1
      Pharmaceutical & Biotech
      Population grade v2
      Academic Medical Center
      Frame 63
      Clinical Diagnostics
      Pharma
      Commercial Data Businesses
      Frame 65
      Biobanks & Population Programs
      Culture-Black
      Regulatory Solutions
    • SOLUTIONS
      Innovation Hub
      NGS Data Analysis
      Translational Informatics
      Population Genomics
      Trusted Regulatory Spaces
      SERVICES
      Professional Services
      Vector 1344
      Managed Services
      Vector 1344
  • Platform
    • PLATFORM
      The DNAnexus Platform
      Culture-1
      Manage
      Your data, organized and managed in one place
      Analyze
      Analyze
      A comprehensive suite of bioinformatics tools
      Population grade-1
      Collaborate
      Powering collaborative exploration and discovery
      Security & Compliance-1
      Security & Compliance
      Comply with regulations, standards, and frameworks
    • LATEST
      Press Releases
      Our latest announcements and coverage
      Read More
  • Partners
    • PARTNERS
      Providers-Black
      Cloud Partners
      Genomics Data-Black
      Technology Partners
      Proteomics data-Black
      Services Partners
      Data Providers-Black
      Data & Biobank Partners
      LIMS-2-Black
      Instrument Partners
    • UK BIOBANK
      ukb-image-1
      Learn more about the UK Biobank Research Analysis Platform
  • Resources
    • RESOURCES
      Learn more with webinars, case studies, white papers and videos
      Developer Resources
      Vector 1344
      Documentation
      Vector 1344
      Status Updates
      Vector 1344
    • resource-image-1
      Learn more with webinars, case studies, white papers, partner briefs and videos
      Blogs
      Group 5453
  • Company
    • COMPANY
      About
      About DNAnexus
      Population grade
      Leadership Team
      Careers
      Careers
      Data Providers-2-Black
      Legal
    • LATEST
      Latest News
      Our latest news and press coverage
      Read More
      MORE DNAnexus
      Events
      Vector 1344
      Contact Us
      Vector 1344
  • Solutions
    • INDUSTRIES
      Bioinformatician-1
      Pharmaceutical & Biotech
      Population grade v2
      Academic Medical Center
      Frame 63
      Clinical Diagnostics
      Pharma
      Commercial Data Businesses
      Frame 65
      Biobanks & Population Programs
      Culture-Black
      Regulatory Solutions
    • SOLUTIONS
      Innovation Hub
      NGS Data Analysis
      Translational Informatics
      Population Genomics
      Trusted Regulatory Spaces
      SERVICES
      Professional Services
      Vector 1344
      Managed Services
      Vector 1344
  • Platform
    • PLATFORM
      The DNAnexus Platform
      Culture-1
      Manage
      Your data, organized and managed in one place
      Analyze
      Analyze
      A comprehensive suite of bioinformatics tools
      Population grade-1
      Collaborate
      Powering collaborative exploration and discovery
      Security & Compliance-1
      Security & Compliance
      Comply with regulations, standards, and frameworks
    • LATEST
      Press Releases
      Our latest announcements and coverage
      Read More
  • Partners
    • PARTNERS
      Providers-Black
      Cloud Partners
      Genomics Data-Black
      Technology Partners
      Proteomics data-Black
      Services Partners
      Data Providers-Black
      Data & Biobank Partners
      LIMS-2-Black
      Instrument Partners
    • UK BIOBANK
      ukb-image-1
      Learn more about the UK Biobank Research Analysis Platform
  • Resources
    • RESOURCES
      Learn more with webinars, case studies, white papers and videos
      Developer Resources
      Vector 1344
      Documentation
      Vector 1344
      Status Updates
      Vector 1344
    • resource-image-1
      Learn more with webinars, case studies, white papers, partner briefs and videos
      Blogs
      Group 5453
  • Company
    • COMPANY
      About
      About DNAnexus
      Population grade
      Leadership Team
      Careers
      Careers
      Data Providers-2-Black
      Legal
    • LATEST
      Latest News
      Our latest news and press coverage
      Read More
      MORE DNAnexus
      Events
      Vector 1344
      Contact Us
      Vector 1344
Sign Up Log In
Request a Demo
Sign Up Log In
Request a Demo
Back to Press Release Page

Back to Press Release Page

Press Releases

DNAnexus Named to the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies

Company Recognized for Three-Year Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses

MOUNTAIN VIEW, Calif. — August 11, 2026 — DNAnexus today announced it has been named to the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. The list is the most prestigious ranking of the nation’s prominent independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia. 
 
"Inclusion in the Inc. 5000 fastest-growing companies reflects the trust the world's leading health and life sciences organizations place in DNAnexus," said Thomas Laur, CEO of DNAnexus. "For years, we have empowered them to turn their omics data into governed, AI-ready assets, fueling the discoveries that improve patient outcomes. Our exceptional growth over the past few years signals the rapid emergence of the molecular data object across Healthcare. As omics and AI converge, DNAnexus has become the clear standard for turning that convergence into scientific breakthroughs.”

The recognition caps a period of accelerating growth for DNAnexus, the platform where frontier science happens. Founded in 2009, it has become foundational to modern scientific pursuits. DNAnexus is home to the largest globally connected community of scientists, spanning over 64,000 researchers across 54 countries and 130+ enterprises, running on 135+ petabytes of omics data. Omics is the world's most complex data in healthcare as it is longitudinal, multimodal, computationally heavy, and subject to the most rigorous regulatory scrutiny in science. DNAnexus turns omics data into a reusable, enterprise-grade asset, validated to the same standard whether a scientist or an AI model acts on it. It is where AI is orchestrated across the precision health ecosystem, and where data becomes discovery at an unmatched industrial scale.

This year’s Inc. 5000 recognizes a new class of companies redefining what growth looks like. From AI and advanced manufacturing to healthcare, consumer products, and professional services, these businesses are expanding their impact, creating jobs and proving that entrepreneurial ambition continues to fuel the U.S. economy. Among the 5,000 companies on the list, the median three-year revenue growth rate was 130%, and those companies have collectively added more than 627,208 jobs to the U.S. economy over the past three years. 
 
For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.inc.com/inc5000. 

“Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still,” says Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.” 

About DNAnexus

Founded in 2009, DNAnexus is the world's most trusted platform for omics data enablement, transforming the most complex data in healthcare into a governed, AI‑ready, reusable asset. DNAnexus gives pharmaceutical, diagnostic, health system, biobank, and regulatory organizations a single platform to contextualize, orchestrate, and federate multimodal omics data, translating it into a source code for discovery. Today, DNAnexus is where the largest globally connected community of scientists synthesizes biological intelligence at unmatched industrial scale. More than 64,000 researchers across 54 countries and 130+ enterprise customers run production‑grade and regulatory‑grade omics work on DNAnexus, processing 135+ petabytes of genomic and multimodal data. Learn more at dnanexus.com.

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

-###-


Inc. 5000 List Methodology 
Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

Media Contacts:

Stephanie Hall, Pitch PR
stephanie@pitchpublicrelations.com
480.216.5422

Kirstin Robison, Pitch PR
krobison@pitchpublicrelations.com
480.363.5371

DNAnexus

  • DNAnexus Platform
  • Professional Services
  • Our Partners
  • About DNAnexus
  • Careers
  • Resource Center
  • Developer Resources
  • Documentation
  • Status Updates
  • Site Map

  • Legal
  • Privacy
  • Terms
  • Security Certifications
© 2026 DNAnexus, Inc. All Rights Reserved.